CD8 T cells were reported to be inversely distributed with FasL-expressing malignant T cells in CTCL skin lesions, implying that the malignant T cells might use FasL to eliminate tumor-reactive CD8 T cells (Ni et al., 2001). This evidence concerns the gene FASLG and primary cutaneous T-cell non-Hodgkin lymphoma.